The synthesis, spectroscopic characterization and in vitro antitumour activity of two triorganotin compounds, triphenyltin ortho-aminophenylthiolate (1) and triphenyltin 2-pyridylthiolate, compound (2) are reported. The structure of 1 is confirmed by X-ray diffraction, with the tin atom in a distorted tetrahedral geometry because of monodentate coordination, as a thiolate (Sn-,S 2.431(2) A), of the ortho-aminophenylthiolate ligand. The in vitro antitumour activities of 1 and 2, against a number of cell lines, are comparable to those exhibited by methotrexate and doxorubicin, and higher than those of carboplatin and cisplatin.
Introduction
Diorganotin bis (2-pyridylthiolates) [1] exhibit an in vitro antitumour activity against MCF-7, a mammary tumour, and WiDr, a colon carcinoma (ID5o: 300 500 and 900 1300, respectively) comparable to that of cisplatin (850 and 624).
Because triphenyltin compounds are usually more active than di-n-butyltin derivatives [2] , the most active of the diorganotin compounds, we synthesized triphenyltin ortho-aminophenyl-and 2-pyridyl-thiolates and screened their the antitumour properties in vitro.
Results and Discussion

Syntheses
Triphenyltin o-aminophenylthiolate, compound 1, and triphenyltin 2-pyridylthiolate, compound 2, X-ray structure of compound 1 Single crystals suitable for X-ray structure determination were obtained for compound 1, but a full analysis for compound 2 was not obtained (see Experimental) . The molecular structure of 1, shown in Fig. 1 , with the main interatomic parameters listed in the caption, is in agreement with a previous report [3] . The Sn atom exists in a distorted tetrahedral geometry defined by the three phenyl substituents and the S atom derived from a monodentate ortho-aminophenylthiolate ligand; Sn-S 2.431 (2) .N o evidence was found for a significant interaction between the Sn and N(1) Clearly, the orientation of the amino group away from the Sn atom in 1 occurs to facilitate the formation .of hydrogen bonding contacts, a situation that can not occur for the dimethylated analogueA full structure determination could not be achieved for2 because of crystal disorder. The analysis confirmed nevertheless the generation of the desired compound and showed that the triorganotin center is coordinated by the S atom, leading to a distorted tetrahedral geometry; a weak intramolecular interaction with the pyridine-N atom is evident.
Spectroscopic characterization of compounds I and 2 13 119 119
The compounds were characterized bylH, C, Sn NMR and Sn MSssbauer spectroscopy (see 13 Experimental Section). 13C assignments were achieved from the comparison of C{ H} standard and DEPT spectra as well as from aromatic chemical shift increment calculations [6] . MEssbauer spectra were obtained as described previously [8] .
The in vitro antitumour screenings were performed as described earlier [9] . 
